Bortezomib sensitizes thyroid cancer to BRAF inhibitor in vitro and in vivoKoji Tsumagari, Emad Kandil|Endocrine Related Cancer|2017Cited by 28
New Insights into the Link between Melanoma and Thyroid Cancer: Role of Nucleocytoplasmic TraffickingMourad Zerfaoui, Emad Kandil|Cells|2021Cited by 19